Ovation Science Inc.
OVAT.CNCNQHealthcare● Active
$0.02
$-0.01(-40.00%)
Market Cap$478643
P/E Ratio—
52W High$0.06
52W Low$0.015
Ovation Science Inc. (OVAT.CN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OVAT.CN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.07M | $0.11M | $0.06M | $0.14M | $0.22M |
| Cost of Revenue | $0.38M | $0.03M | $0.31M | $0.00M | $0.39M |
| Gross Profit | ($0.31M) | $0.09M | ($0.25M) | $0.13M | ($0.17M) |
| Gross Margin %(computed) | -460.26% | 75.71% | -405.97% | 97.07% | -75.02% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.01M | $0.01M | $0.07M | $0.08M |
| G&A Expenses | $0.33M | $0.25M | $0.46M | $0.43M | $0.39M |
| Total Operating Expenses | $0.29M | $0.56M | $0.81M | $0.56M | $0.86M |
| Operating Income | ($0.60M) | ($0.48M) | ($0.76M) | ($0.79M) | ($2.40M) |
| Operating Margin %(computed) | -881.14% | -423.12% | — | -573.54% | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.05M | $0.05M | $0.03M | $0.00M | $0.00M |
| Income Before Tax | ($0.63M) | ($0.46M) | ($0.81M) | ($0.79M) | ($2.39M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.63M) | ($0.46M) | ($0.81M) | ($0.79M) | ($2.39M) |
| Net Margin %(computed) | -929.86% | -402.95% | — | -574.76% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.01 | $-0.03 | $-0.03 | $-0.08 |
| Wtd Avg Shares | 35.60M | 34.98M | 30.32M | 29.37M | 29.37M |
| EBITDA | ($0.60M) | ($0.40M) | ($0.78M) | ($0.79M) | ($2.39M) |
| EBITDA Margin %(computed) | -881.14% | -356.97% | — | -569.46% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more Ovation Science Inc. data
About Ovation Science Inc. (OVAT.CN) Income Statement
Ovation Science Inc. (OVAT.CN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OVAT.CN reported revenue of $0.00B, gross profit of ($0.00B) (gross margin -460.26%), and net income of ($0.00B) — a net profit margin of -929.86%.
Frequently asked questions
OVAT.CN · 4 questionsOvation Science Inc. (OVAT.CN) reported revenue of $0.00B for 2025, down 40.0% year-over-year.
OVAT.CN revenueOVAT.CN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09